FMISO
FMISO or fluoromisonidazole is used as a PET radiotracer for imaging hypoxia when labeled with fluorine-18.[1]
 | |
| Clinical data | |
|---|---|
| Other names | [18F]FMISO; 1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole |
| Identifiers | |
IUPAC name
| |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C6H818FN3O |
| Molar mass | 188.15 g/mol |
References
- Rajendran, JG; Mankoff, DA; O'Sullivan, F; Peterson, LM; Schwartz, DL; Conrad, EU; Spence, AM; Muzi, M; Farwell, DG; Krohn, KA (1 April 2004). "Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging". Clinical Cancer Research. 10 (7): 2245–52. doi:10.1158/1078-0432.ccr-0688-3. PMID 15073099.
External links
- 18F-Fluoromisonidazole, Molecular Imaging and Contrast Agent Database (MICAD)
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.